Home › Therapeutic areas › Oncology › Gastroesophageal Junction Cancer

Gastroesophageal Junction Cancer (3 companies)

Companies with an active program in Gastroesophageal Junction Cancer.

Ticker	Company	Therapeutic areas	Programs	Lead stage	Mkt cap	Programs
CTMX	CytomX Therapeutics	Oncology	1	Phase 1	$477M	7
XNCR	Xencor	ImmunologyNeurology+1 Rare	1	Approved	$2.68B	28
ZYME	Zymeworks	OncologyRespiratory	1	Approved	$2.10B	11